The modding scene for Morrowind has reached a new milestone with the April 2026 release of OpenMW 0.51.0 in its Release Candidate phase. While the engine promises better performance and stability, the ...
Highlights of Python 3.15, now available in beta, include lazy imports, faster JITs, better error messages, and smarter ...
Reading a book about bowling is not the same as actually bowling. If that resonates with you and you want to learn more about ...
Compare the best AI image generators, including Gemini, ChatGPT, Midjourney, Firefly, Ideogram, FLUX, Recraft, Stable ...
The founders of Degen spent years inside the biggest platforms watching how the systems actually work. What they saw ...
Three Arizona women have filed a lawsuit against a group of men that alleges they used the women’s photos to make AI porn ...
Round 1 of the 2026 NFL Draft is in the books, and it was all about protecting the quarterback. While none were taken in the first eight picks, nine offensive linemen heard their names called among ...
Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Generate Biomedicines, Inc. (GENB) announced the pricing of its initial public offering of 25 million shares of common stock at $16.00 per share. The clinical-stage generative biology company expects ...
Generate Biomedicines describes itself as a company focused on AI-driven biotechnology and drug design and development. A registration statement relating to the securities was declared effective by ...
Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...